Neurotronics, a Nihon Kohden company, today announced that the U.S. Food and Drug Administration (FDA) has granted 510 (k) clearance for its Sleep Analysis Module (SAM).
SimActive and Phase One streamline large-scale defense mapping, helping users process thousands of high-resolution aerial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results